ストックスクリーナーアプリを入手
4.7633
0.83%
-0.0567
前日終値:
$4.82
開ける：
$4.85
24時間の取引高:
200.07K
Relative Volume:
0.12
時価総額：
$656.74M
収益：
$288.95M
当期純損益:
$-119.03M
株価収益率:
8.364
EPS:
0.5695
ネットキャッシュフロー:
$60.67M
1週間 パフォーマンス:
-8.08%
1か月 パフォーマンス:
-43.76%
6か月 パフォーマンス:
-56.35%
1年 パフォーマンス:
-3.04%
1日の値動き範囲:
$4.745
$4.90
1週間の範囲:
$4.275
$5.365
52週間の値動き範囲:
$4.275
$11.55
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
名前
Maravai Lifesciences Holdings Inc
セクター
電話
(858) 546-0004
住所
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
MRVI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| MRVI | 4.78 | 656.74M | 288.95M | -119.03M | 60.67M | 0.5695 |
| VRTX | 445.00 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 736.17 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 583.62 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 247.09 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.19 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-08-08 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | ダウングレード | Goldman | Buy → Neutral |
| 2023-01-05 | ダウングレード | UBS | Buy → Neutral |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-11-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2020-12-16 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | 開始されました | BofA Securities | Buy |
| 2020-12-15 | 開始されました | Credit Suisse | Outperform |
| 2020-12-15 | 開始されました | Goldman | Buy |
| 2020-12-15 | 開始されました | Jefferies | Buy |
| 2020-12-15 | 開始されました | Robert W. Baird | Outperform |
| 2020-12-15 | 開始されました | Stifel | Buy |
| 2020-12-15 | 開始されました | William Blair | Outperform |
| 2020-12-14 | 開始されました | UBS | Buy |
すべてを表示
Maravai Lifesciences Holdings Inc (MRVI) 最新ニュース
Wolfe Research Initiates Coverage of Maravai LifeSciences Holdings (MRVI) with Peer Perform Recommendation - MSN
What Do Analysts Think About Maravai LifeSciences Holdings Inc’s (NASDAQ:MRVI) Future? - Stocks Register
Royce & Associates LP Increases Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Trading Down 7.5%Here's What Happened - MarketBeat
(MRVI) Trading Report - Stock Traders Daily
Maravai Lifesciences stock hits 52-week low at $4.68 - Investing.com
Steven Cohen's Strategic Acquisition in Maravai LifeSciences - GuruFocus.com
Maravai LifeSciences shares initiated with Peerperform on positive aspects - Investing.com India
Maravai lifesci director John DeFord acquires $100,625 in stock - Investing.com
Insider Buying: Director John Deford Acquires Shares of Maravai LifeSciences Holdings Inc (MRVI) - GuruFocus.com
Maravai LifeSciences shares initiated with Peerperform on positive aspects By Investing.com - Investing.com Canada
Maravai LifeSciences (NASDAQ:MRVI) Now Covered by Wolfe Research - MarketBeat
Maravai LifeSciences Target of Unusually Large Options Trading (NASDAQ:MRVI) - MarketBeat
12 West Capital Management LP's Strategic Acquisition in Maravai LifeSciences Holdings Inc - GuruFocus.com
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Up Following Insider Buying Activity - MarketBeat
Maravai LifeSciences Announces November 2024 Investor Conference Schedule - GlobeNewswire
Earnings call: Maravai LifeSciences reports mixed Q3 results, eyes growth - Investing.com India
Maravai LifeSciences (NASDAQ:MRVI) Price Target Cut to $13.00 by Analysts at Royal Bank of Canada - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q3 2024 Earnings Call Transcript - Insider Monkey
Slammed 37% Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Screens Well Here But There Might Be A Catch - Simply Wall St
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down on Analyst Downgrade - Defense World
Maravai Lifesciences price target lowered to $9 from $10 at Baird - Yahoo Finance
Health Care Up on Another Round of Mixed Earnings -- Health Care Roundup - Marketscreener.com
Royal Bank of Canada Has Lowered Expectations for Maravai LifeSciences (NASDAQ:MRVI) Stock Price - MarketBeat
Maravai LifeSciences stock plunges 39% amid lowered revenue forecast - MSN
Maravai LifeSciences stock plunges 39% amid lowered revenue forecast (NASDAQ:MRVI) - Seeking Alpha
U.S. Stock market: Evolent Health(-43.35%), Maravai LifeSciences(-38.65%), and Chanson International(-38.04%) in midday trading - Business Upturn
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down Following Analyst Downgrade - MarketBeat
U.S. Stock market: Evolent Health (-41.07%), Maravai LifeSciences(-34.44%), Revance Therapeutics(-32.01%) as top losers during early trading - Business Upturn
Maravai LifeSciences (NASDAQ:MRVI) Given New $9.00 Price Target at Robert W. Baird - MarketBeat
Maravai LifeSciences' (MRVI) Market Perform Rating Reaffirmed at William Blair - MarketBeat
Decoding 5 Analyst Evaluations For Maravai LifeSciences - Benzinga
Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript - AOL
Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ... By GuruFocus - Investing.com Canada
Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ... - Yahoo Finance
Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research - BioSpace
Maravai LifeSciences Reports Q3 Earnings and Strategic Acquisition - TipRanks
Maravai LifeSciences stock plunges on weak Q3 results, lowered guidance By Investing.com - Investing.com South Africa
Maravai LifeSciences stock plunges on weak Q3 results, lowered guidance - Investing.com
Maravai Lifesciences earnings missed by $0.01, revenue fell short of estimates - Investing.com UK
Maravai to acquire Officinae Bio's DNA, RNA business By Investing.com - Investing.com South Africa
Maravai LifeSciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Maravai LifeSciences Reports Third Quarter 2024 Financial Results - GlobeNewswire
Maravai LifeSciences Holdings Inc (MRVI) Recovers 77.65% From Low: Are We There Yet? - Stocks Register
Maravai LifeSciences Holdings (STU:MAR) Growth Rank : 8 (As of Nov. 05, 2024) - GuruFocus.com
(MRVI) Investment Analysis and Advice - Stock Traders Daily
Maravai LifeSciences Holdings (STU:MAR) GF Value Rank : 9 (As of Nov. 05, 2024) - GuruFocus.com
MRVI Stock Surges Amid Biotechnology Sector Fluctuations - GuruFocus.com
Cannon Global Investment Management LLC Makes New $590,000 Investment in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Roubaix Capital LLC Trims Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Maravai Lifesciences Holdings Inc (MRVI) 財務データ
収益
当期純利益
現金流量
EPS
Maravai Lifesciences Holdings Inc (MRVI) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| HULL CARL | See Remarks |
Nov 11 '24 |
Buy |
5.64 |
175,000 |
987,000 |
175,000 |
| GTCR INVESTMENT XI LLC | Director |
May 28 '24 |
Sale |
9.81 |
9,940,974 |
97,570,660 |
20,150,005 |
0.42%
0.16%
大文字化:
|
ボリューム (24 時間):